logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
J

Jan-Erik Frödin

karolinska institutet
H指数:32
被引数:3,090

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Tolerability of dose-escalating early postoperative intraperitoneal chemotherapy in colorectal cancer with peritoneal disease: EFFIPEC single-arm phase I study

结直肠癌伴腹膜病变患者中剂量递增早期术后腹腔化疗的耐受性：EFFIPEC单臂I期研究

BJS Open
IF4.5
2026-10-050
OAAI
Elinor Bexe Lindskog; Lana Ghanipour; Gabriella Jansson Palmer; Dan Asplund; Caroline Nordenvall; Helgi Birgisson; Ingvar Syk; Torbjörn Swartling; Per J Nilsson; Jan-Erik Frödin; Victor Verwaal; Wilhelm Graf; Peter Cashin
Perioperative immune checkpoint inhibitor therapy across tumors: Insights and shared lessons from a rapidly evolving field

围手术期免疫检查点抑制剂疗法：从快速发展的领域获得的见解与共同经验

Journal of Internal Medicine
IF9.2
2026-02-140
OAAI
Karl Björkström; Alexios Matikas; Fernanda Costa Svedman; Einar Björgvinsson; Mark Zupancic; Lisa Villabona; Hanna Eriksson; Marcus Skribek; Josefin Fernebro; Magnus Lindskog; Jan-Erik Frödin; Anders Ullén; Simon Ekman; Hildur Helgadottir
Dalotuzumab in chemorefractory KRAS exon 2 mutant colorectal cancer: Results from a randomised phase II/III trial

Dalotuzumab在化学难治性KRAS外显子2突变型结直肠癌中的应用: 一项随机II/III期试验的结果

INTERNATIONAL JOURNAL OF CANCER
IF4.7
2016-10-175
OAAI
Sclafani, Francesco; Kim, Tae Y.; Cunningham, David; Kim, Tae W.; Tabernero, Josep; Schmoll, Hans J.; Roh, Jae K.; Kim, Sun Y.; Park, Young S.; Guren, Tormod K.; Hawkes, Eliza; Clarke, Stephen J.; Ferry, David; Frodin, Jan-Erik; Ayers, Mark; Nebozhyn, Michael; Peckitt, Clare; Loboda, Andrey; Watkins, David J.
A Randomized Phase II/III Study of Dalotuzumab in Combination With Cetuximab and Irinotecan in Chemorefractory, KRAS Wild-Type, Metastatic Colorectal Cancer
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE
IF7.2
2015-09-2380
OAAI
Sclafani, Francesco; Kim, Tae Y.; Cunningham, David; Kim, Tae W.; Tabernero, Josep; Schmoll, Hans J.; Roh, Jae K.; Kim, Sun Y.; Park, Young S.; Guren, Tormod K.; Hawkes, Eliza; Clarke, Steven J.; Ferry, David; Frodin, Jan-Erik; Ayers, Mark; Nebozhyn, Michael; Peckitt, Clare; Loboda, Andrey; Mauro, David J.; Watkins, David J.
A randomized phase III trial on maintenance treatment with bevacizumab alone or in combination with erlotinib after chemotherapy and bevacizumab in metastatic colorectal cancer: the Nordic ACT Trial

转移性结直肠癌化疗后单用贝伐单抗或联合厄洛替尼维持治疗的随机III期临床试验: 北欧ACT试验

ANNALS OF ONCOLOGY
IF65.4
2013-09-0166
OAAI
Johnsson, A.; Hagman, H.; Frodin, J. -E.; Berglund, A.; Keldsen, N.; Fernebro, E.; Sundberg, J.; Christensen, R. De Pont; Spindler, K-L. Garm; Bergstrom, D.; Jakobsen, A.

研究方向

暂未获取到该数据
B
Bengt Glimelius
H 指数:115论文数:1,002被引数:7.4万
Å
Åke Berglund
H 指数:28论文数:68被引数:5,294
P
Per Byström
H 指数:13论文数:31被引数:1,127
P
Per Pfeiffer
H 指数:60论文数:548被引数:2.1万
A
Anders Jakobsen
H 指数:59论文数:600被引数:1.4万
P
Peter Cashin
H 指数:19论文数:84被引数:1,578
S
Simon Ekman
H 指数:31论文数:207被引数:6,281
J
Johan Harmenberg
H 指数:27论文数:113被引数:2,520
M
Michael Bergqvist
H 指数:32论文数:191被引数:3,453
I
Ingvar Syk
H 指数:33论文数:132被引数:3,989